Alterity Therapeutics
Quarterly Financials
| Values in thousands | 2025-06-30 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|
Revenue | $3,832 | $1,605 | $802 |
Gross Profit | 3,769 | 1,542 | 771 |
EBITDA | -7,107 | -7,525 | -3,762 |
EBIT | -7,118 | -7,542 | -3,771 |
Net Income | -4,974 | -7,173 | -3,586 |
Net Change In Cash | 3,832 | 1,605 | 802 |
Free Cash Flow | -2,355 | -8,359 | -4,179 |
Cash | 33,158 | 4,536 | 4,536 |
Basic Shares | 12,467 | 8,855 | 8,855 |
Annual Financials
| Values in thousands | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|---|
Revenue | $5,438 | $4,019 | $3,916 | $5,123 |
Gross Profit | 5,311 | 3,804 | 3,631 | 4,758 |
EBITDA | -14,633 | -19,571 | -14,598 | -17,392 |
EBIT | -14,661 | -19,606 | -14,636 | -17,446 |
Net Income | -12,147 | -19,123 | -13,806 | -12,847 |
Net Change In Cash | 5,438 | 4,019 | 3,916 | 5,123 |
Free Cash Flow | -11,451 | -12,611 | -20,043 | -12,426 |
Cash | 33,158 | 12,638 | 15,773 | 34,806 |
Basic Shares | 10,661 | 6,081 | 4,046 | 4,009 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-06-30 | $0 |
2024-12-31 | $0 |
2023-03-31 | $0 |
2022-12-31 | $0 |
